Time and Economic Burden of Comorbidities Among COPD Inpatients

详细信息    查看全文

• 关键词：COPD ; Comorbidity ; Time burden ; Economic burden ; Inpatient ; CCI ; Population study
• 刊名：Lecture Notes in Computer Science
• 出版年：2016
• 出版时间：2016
• 年：2016
• 卷：9545
• 期：1
• 页码：187-195
• 全文大小：98 KB
• 参考文献：1.Celli, B.R., MacNee, W., Agusti, A., et al.: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 23, 932–946 (2004)CrossRef
  2.Top 10 causes of death. http://​www.​who.​int/​mediacentre/​factsheets/​fs310/​en/​
  3.Guarascio, A.J., Ray, S.M., Finch, C.K., Self, T.H.: The clinical and economic burden of chronic obstructive pulmonary disease in the USA. ClinicoEconomics and Outcomes Res.: CEOR 5, 235–245 (2013)
  4.Sin, D.D., Anthonisen, N.R., Soriano, J.B., Agusti, A.G.: Mortality in COPD: role of comorbidities. Eur. Respir. J. 28, 1245–1257 (2006)CrossRef
  5.Fabbri, L.M., Luppi, F., Beghe, B., Rabe, K.F.: Complex chronic comorbidities of COPD. Eur. Respir. J. 31, 204–212 (2008)CrossRef
  6.Rana, J.S., Mittleman, M.A., Sheikh, J., et al.: Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care 27, 2478–2484 (2004)CrossRef
  7.Schmidt, M.I., Duncan, B.B., Sharrett, A.R., et al.: Markers of inammation and prediction of diabetes mellitus in adults (atherosclerosis risk in communities study): a cohort study. Lancet 353, 1649–1652 (1999)CrossRef
  8.Sharabiani, M.T.A., Aylin, P., Bottle, A.: Systematic review of comorbidity indices for administrative data. Med. Care 50, 1109–1118 (2012)CrossRef
  9.Charlson, M.E., Pompei, P., Ales, K.L., Mackenzie, C.R.: A new method of classifying prognostic co-morbidity in longitudinal-studies - development and validation. J. Chron. Dis. 40, 373–383 (1987)CrossRef
  10.Sundararajan, V., Henderson, T., Perry, C., et al.: New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J. Clin. Epidemiol. 57, 1288–1294 (2004)CrossRef
  11.Lin, P.J., Shaya, F.T., Scharf, S.M.: Economic implications of comorbid conditions among Medicaid beneficiaries with COPD. Resp. Med. 104, 697–704 (2010)CrossRef
  12.Evans, D.C., Cook, C.H., Christy, J.M., et al.: Comorbidity-polypharmacy scoring facilitates outcome prediction in older trauma patients. J. Am. Geriatr. Soc. 60, 1465–1470 (2012)CrossRef
  13.Van Walraven, C., Austin, P.C., Jennings, A., et al.: A modification of the elixhauser comorbidity measures into a point system for hospital death using administrative data. Med. Care 47, 626–633 (2009)CrossRef
  
• 作者单位：Jiaqi Liu (17)
  James Ma (19)
  Jiaojiao Wang (17)
  Daniel Zeng (17)
  Hongbin Song (20)
  Ligui Wang (20)
  Zhidong Cao (17) (18)
  
  17. The State Key Laboratory of Management and Control for Complex Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, China
  19. College of Business, University of Colorado, Colorado Springs, USA
  20. Institute of Disease Control and Prevention, Academy of Military Medical Sciences, Beijing, China
  18. Cloud Computing Center, Chinese Academy of Sciences, Dongguan, China
  
• 丛书名：Smart Health
• ISBN：978-3-319-29175-8
• 刊物类别：Computer Science
• 刊物主题：Artificial Intelligence and Robotics
  Computer Communication Networks
  Software Engineering
  Data Encryption
  Database Management
  Computation by Abstract Devices
  Algorithm Analysis and Problem Complexity
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1611-3349

文摘

Chronic obstructive pulmonary disease (COPD) is a major public health problem and usually associated with various comorbidities. Base on electronic health records of inpatients, aged 40 to 80 years old, from 169 hospitals located across China between 2013 and 2014, this paper summarized 27 comorbidities of COPD and compared the time and economic burdens of COPD patients to non-COPD patients. The 17 comorbidities included in Charlson Comorbidity Index (CCI) and 10 additional comorbidities were employed while odds ratios were considered to compare differences. The results disclosed that COPD patients had higher comorbidity burdens than non-COPD patients did. Moreover, COPD patients had 6.40 % more hospital stay and 12.96 % lower medical cost. Seven morbidities had positive correlations with hospital stay and medical cost, which indicated that COPD patients should be paid more attention to those comprehensive comorbidities when making therapeutic plans.